MPLT - Company ID 0001770069
The table below shows MapLight Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 |
|---|---|---|
| Cash & equivalents | $55.71M | $64.15M |
| Short-term investments | $254.41M | $163.02M |
| Receivables | - | - |
| Inventory | - | - |
| Total current assets | $327.23M | $245.31M |
| Property, plant & equipment | $968.00K | $859.00K |
| Goodwill | - | - |
| Total assets | $418.79M | $257.22M |
| Accounts payable | $3.19M | $2.45M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current liabilities |
| $14.28M |
| $18.56M |
| Long-term debt | - | - |
| Total liabilities | $18.95M | $23.71M |
| Retained earnings | -$421.19M | -$280.97M |
| Total equity | $399.83M | -$274.18M |